Trial Profile

Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms (SPARE)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Isoflavone/soybean protein (Primary)
Indications Menopause; Metabolic bone diseases; Osteoporosis
Focus Therapeutic Use
Acronyms SPARE

Most Recent Events

06 Dec 2016 Biomarkers information updated
13 Sep 2011 New trial record
08 Aug 2011 Results published in the Archives of Internal Medicine indicate that the trial was conducted from 1 July 2004 to the 31 March 2009.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com